Stock Screener App

Frei -

Installieren

17.61

3.98% -0.73

after-market

Handel nachbörslich: 17.60 -0.010 -0.06%

Denali Therapeutics Inc (DNLI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Denali Therapeutics Inc-Aktie (DNLI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.604	-	-	-	-
Cost Of Revenue	0.093	-	-	-	-
Selling, General, and Administrative	36.28	-	-	-	-
Costs And Expenses	134.15	-	-	-	-
Operating Income/Loss	4.96% -130.54	-137.36	-137.37	-137.43	-134.96
Net Income/Loss	0.70% -127.55	-128.45	-128.55	-126.90	-124.12
Basic Average Shares	0.36% 187.31	186.64	0.9469	172.42	171.45
Diluted Average Shares	0.36% 187.31	186.64	0.9469	172.42	171.45
Basic Earnings Per Share	1.45% -0.68	-0.69	-0.73	-0.74	-0.72
Diluted Earnings Per Share	1.45% -0.68	-0.69	-0.73	-0.74	-0.72

PBLS

$22.75

9.65%

CELC

$56.58

6.17%

ELVN

$37.32

5.11%

NRIX

$24.42

2.12%

DYN

$14.25

6.80%

ZLAB

$23.19

1.36%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters